Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

Outbreaks of emerging infections present health professionals with the unique challenge of trying to select appropriate pharmacologic treatments in the clinic with little time available for drug testing and development. Typically, clinicians are left with general supportive care and often untested c...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Dyall, Julie, Coleman, Christopher M., Hart, Brit J., Venkataraman, Thiagarajan, Holbrook, Michael R., Kindrachuk, Jason, Johnson, Reed F., Olinger, Gene G., Jahrling, Peter B., Laidlaw, Monique, Johansen, Lisa M., Lear-Rooney, Calli M., Glass, Pamela J., Hensley, Lisa E., Frieman, Matthew B.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Microbiology 2014
الموضوعات:
Antiviral Agents
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4136000/
https://ncbi.nlm.nih.gov/pubmed/24841273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03036-14
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة